to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction
Clinical trial NCT05162261 · COMPLETED
Trial details
- NCT number
- NCT05162261
- Sponsor
- Novoxel Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-19
- Primary completion
- 2023-04-26
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.